SPOREGEN LIMITED
Company number 08001035 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
£815,458
Balance sheet as at 2025-03-31
Overview
- Company type
- Private Limited Company
- Incorporated
- 2012-03-22
- Employees
- 4 (2025 accounts)
- Registered office
- The London Bioscience Innovation Centre, 2 Royal College Street, London, England, NW1 0NH
- Postcode
- NW1 0NH
- Capital
- 201 GBP
- Accounts category
- Total Exemption Full
Accounts
- Last made up to
- 2025-03-31
- Next due by
- 2026-12-31
- Financial year end
- 31 March
Confirmation statement
- Last statement dated
- 2025-11-23
- Next due by
- 2026-12-07
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 1 current · 5 resigned
Licensed visa sponsor
Licensed by the Home Office to sponsor worker visas: Skilled Worker (Worker (A rating)).
Matched by registered name to the register of licensed sponsors (Home Office, updated daily) — check the register itself before relying on it. Contains public sector information licensed under the Open Government Licence v3.0.
Contact details
- Website
- sporegen.com
The only company worldwide working exclusively on Bacillus and its applications
Previous company names
| Name | Date changed |
|---|---|
| HOLLOWAY IMMUNOLOGY LTD | 2013-12-19 |
Previous registered addresses 3
| Address | Changed on |
|---|---|
| BOURNE LABORATORIES ROYAL HOLLOWAY UNIVERSITY OF LONDON, EGHAM, SURREY, TW20 0EX, UNITED KINGDOM | 2019-11-04 |
| JAMES COWPER KRESTON 8TH FLOOR SOUTH, READING BRIDGE HOUSE, GEORGE STREET, READING, RG1 8LS, ENGLAND | 2018-04-24 |
| 3 WESLEY GATE, QUEENS ROAD, READING, BERKSHIRE, RG1 4AP | 2016-02-18 |
Among its peers
Top 25%
by shareholders' funds, of 44 similar companies in NW
Among the oldest 25% of its local peers, trading since 2012.
No.6 of the largest research and experimental development on biotechnology companies in London →
Competitors London
This company ranks 6 among research and experimental development on biotechnology in London.
The class of 2012
32%
of the 280 companies in this sector incorporated in 2012 are still active today; 66% have since been dissolved.
A fact about the year, not a forecast for this company.